Neonatal jaundice secondary prevention
|
Neonatal jaundice Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Neonatal jaundice secondary prevention On the Web |
|
American Roentgen Ray Society Images of Neonatal jaundice secondary prevention |
|
Risk calculators and risk factors for Neonatal jaundice secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Elsaiey, MBBCH [2]
Overview
According to the American Academy of Pediatrics, secondary prevention of neonatal jaundice is achieved via proper screening tests which include blood typing, clinical assessment of jaundice in the newborns, assessment of the total serum bilirubin level, measuring the level of G6PD enzyme, and it is also recommended for all hospitals to provide information to the parents on jaundice and its consequences.
Secondary Prevention
- According to the American Academy of Pediatrics, screening for neonatal jaundice is recommended. Screening tests include the following:[1]
- Blood typing: Testing the pregnant women for the ABO blood group and Rh body autoantibodies.
- Clinical assessment: Jaundice assessment in the newborns every 8-12 hours. Assessment is performed by blanching the skin to know the color and should be done in the daylight.
- Laboratory evaluation: Measuring the level of the total serum bilirubin level in all newborns in the first day of life.
- Estimating the cause of the jaundice: Measuring the level of the G6PD enzyme.
- Risk Assessment: The newborns should be assessed for the risk of developing jaundice before discharge.
- Also, it is recommended for all hospitals to provide information to the parents on jaundice and its consequences.
References
- ↑ American Academy of Pediatrics Subcommittee on Hyperbilirubinemia (2004). "Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation". Pediatrics. 114 (1): 297–316. PMID 15231951.